Dr. Carlos Henrique Lopes Rocha, USP, Brazil
Carlos Henrique Lopes Rocha. He completed his Bachelor’s degree in Biology at the Federal Institute of Education, Science and Technology of MaranhĂŁo (IFMA) in 2016. He went on to earn a Master’s degree in Parasitology from the University of CEUMA (UNICEUMA) in 2019, where he focused on the antifungal activity of Terminalia catappa leaves. Carlos obtained his Ph.D. in Biological Sciences (Genetics) from the University of SĂŁo Paulo (USP) in 2023, with research centered on the synergistic activity of sertraline combined with antifungal drugs against Trichophyton rubrum. Currently, he is a postdoctoral researcher in the Department of Gynecology and Obstetrics at the Clinics Hospital of RibeirĂŁo Preto, USP. With expertise in microbiology, Carlos specializes in the phenotypic and molecular characterization of environmental and pathogenic microorganisms, as well as in the genetic research of pathogenic fungi and drug repositioning. He has participated in several complementary courses to enhance his scientific communication skills and molecular biology techniques.
Professional Profile:
ORCID
Summary of Suitability for Best Researcher Award conclusion
Carlos Henrique Lopes Rocha’s academic qualifications, innovative research contributions, active participation in the scientific community, and dedication to continuous improvement make him an outstanding candidate for the Best Researcher Award. His work not only advances our understanding of fungal infections but also offers potential pathways for developing new therapeutic strategies.
🎓 Education
- Ph.D. in Biological Sciences (Genetics)
- Institution: University of SĂŁo Paulo (USP), SĂŁo Paulo, Brazil
- Thesis: Synergistic activity of the antidepressant sertraline associated with drugs against Trichophyton rubrum and evaluation of adaptive response mechanisms
- Year Obtained: 2023
- Master’s in Parasitology
- Institution: University of CEUMA (UNICEUMA), Brazil
- Thesis: Investigation of the antifungal activity of the butanol fraction of Terminalia catappa leaves extract in combination with fluconazole in an alternative cryptococcosis model
- Year Obtained: 2019
- Bachelor’s in Biology Education
- Institution: Federal Institute of Education, Science, and Technology of MaranhĂŁo (IFMA), Brazil
- Thesis: Antifungal and anti-virulence activity of the butanol fraction of Terminalia catappa extract in combination with fluconazole against Cryptococcus gattii isolates
- Year Obtained: 2016
🏥 Work Experience
- Postdoctoral Researcher
- Department: Gynecology and Obstetrics, Hospital das ClĂnicas, University of SĂŁo Paulo, RibeirĂŁo Preto, Brazil
- Field: Genetics
- Year: 2024 – Present
🏆 Achievements
- Publications: Authored articles on antifungal activities and genetics of pathogenic fungi, contributing to the field of microbiology.
- Research Focus: Expertise in microbial genetics, characterization of pathogenic microorganisms, and drug repositioning.
🎖️ Awards and Honors
- CAPES Scholarship: Awarded for doctoral studies, showcasing recognition for academic excellence.
- American Chemical Society Courses: Completed courses in scientific communication and writing, reflecting commitment to professional development.
Publication Top Notes:
n -butanol fraction of Terminalia catappa possesses anti-Candida albicans properties and in vivo action on Tenebrio molitor alternative infection model
The Antidepressant Sertraline Affects Cell Signaling and Metabolism in Trichophyton rubrum
Synergism between the Antidepressant Sertraline and Caspofungin as an Approach to Minimise the Virulence and Resistance in the Dermatophyte Trichophyton rubrum
Reassessing the Use of Undecanoic Acid as a Therapeutic Strategy for Treating Fungal Infections
TITLE: SYNERGISM BETWEEN FLUCONAZOLE AND TERMINALIA CATAPPA EXTRACT AND ITS USE IN THE TREATMENT OF CANDIDA-INFECTED TENEBRIO MOLITOR LARVAE / TĂŤTULO: SINERGISMO ENTRE FLUCONAZOL E O EXTRATO DE TERMINALIA CATAPPA E SEU USO NO TRATAMENTO DE LARVAS DE TENEBRIO MOLITOR INFECTADAS COM CANDIDA